Furthermore, the ratio of TYR to filaggrin degradation products is higher in ADFLG when compared to CTRL and ADNON-FLG, suggesting either accumulation of TYR in the SC or alternative pathways in AD patients with FLG mutations which leads to elevated TYR levels. The gene discussed is TYR; the disease is Alzheimer disease.